FDA panel to consider full approval of Pfizer’s COVID-19 drug Paxlovid

A U.S. Food and Drug Administration advisory panel will discuss whether to recommend Pfizer’s COVID-19 treatment Paxlovid for full approval during a meeting Thursday.